Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 4, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

DoW Breast Cancer, Breakthrough Award Level 3

Closed
HT942526BCRPBTA3Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Department of the Army and Defense Health Agency are soliciting applications for the Fiscal Year 2026 Breast Cancer Research Program Breakthrough Award Level 3 under solicitation HT942526BCRPBTA3. This program supports advanced translational studies with high potential to make major breakthroughs in breast cancer research. Applications must address at least one overarching FY26 BCRP challenge and identify the specific patients or at-risk individuals who would benefit. The award supports a maximum performance period of four years, with total funding caps of 5.6 million dollars for single Principal Investigator applications and 7.0 million dollars for Partnering PI Option applications. Approximately 12.6 million dollars is available to fund about two awards. Eligible applicants must be registered in SAM.gov, eBRAP.org, and Grants.gov. The research team must include at least two breast cancer consumer advocates. While not required, small-scale clinical trials such as phase 1/1b are permitted. The application process is a two-step sequence, with pre-applications due June 12, 2026, and full applications due September 30, 2026. Evaluation is conducted through a two-tier process consisting of a peer review for technical merit followed by a programmatic review for relevance to BCRP priorities. Key requirements include the disclosure of foreign affiliations for all key personnel and mandatory approval from the DHA R&D Office of Research and Regulatory Compliance for any research involving human or animal subjects.

General Info

Army and DHA funding breast cancer breakthroughs; max $7M per award, 4 years.

Documents

2

FY26 Breast Cancer Research Program Breakthrough Award Level 3 Funding Opportunity HT942526BCRPBTA3

PDF, High priority: read this firstprogram-announcement
High

HT942526BCRPBTA3 Breast Cancer Research Program Breakthrough Award Level 3

PDF, High priority: read this firstprogram-announcement
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Department Of The Army -- Usamraa
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts
Jamie ShortallGrant Officer

Full Description

Show more

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Level 3.

Distinctive Features:

·        For this funding mechanism, small-scale clinical trials are allowed but not required. Applications proposing projects with a clinical trial should be submitted under the Clinical Trial option.

·        The research team must include two or more breast cancer consumer advocates.

·        This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

More opportunities from Department Of Defense → Department Of The Army -- Usamraa

Same awarding agency

NAICS: 518210
Grant
Data Management and Research Sharing Plan DevelopmentThe contract seeks the design and implementation of a secure, compliant data management plan tailored for biomedical research, with a strong emphasis on preserving data integrity, adhering to FAIR principles—findable, accessible, interoperable, and reusable—and meeting federal requirements for data sharing. The plan must ensure that all research data is handled in a manner that supports long-term preservation, ethical use, and regulatory compliance, particularly under Department of Defense standards. The subcontractor will be responsible for developing structured policies and technical workflows that align with evolving federal mandates, enabling seamless data sharing while maintaining rigorous security protocols to protect sensitive biomedical information. The initiative is managed by the Department of the Army through USAMRAA under the broader Department of Defense, with the NAICS code 518210 indicating its focus on data processing and hosting services. The opportunity is open as a subcontract, with responses due by November 4, 2026. While the physical place of performance and point of contact are not specified, the work must be executed to meet federal compliance timelines and deliverables without reliance on proprietary or non-standard frameworks. The goal is to establish a scalable, audit-ready data infrastructure that supports ongoing and future biomedical research initiatives under federal oversight.
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services

POSTED

4 months ago

DEADLINE

in 10 days
View Details
NAICS: 541715
Grant
DoW Reconstructive Transplant, Concept Award
Solicitation # HT942526RTRPCA
The Defense Health Agency Contracting Activity is soliciting applications for the fiscal year 2026 Reconstructive Transplant Research Program Concept Award under solicitation HT942526RTRPCA. This program supports the exploration of highly innovative new concepts or untested theories that address critical problems in reconstructive transplantation, specifically those aligned with FY26 RTRP Focus Areas. The award is designed for high-risk, high-reward research that introduces new paradigms or creative perspectives, and it explicitly excludes clinical trials and incremental advances based on existing data. Early-career investigators at or above the postdoctoral fellow level are encouraged to apply. Funding is capped at 200,000 dollars per award for a maximum period of performance of 18 months, with an overall program appropriation of 12 million dollars. The selection process involves a two-tier review consisting of a peer review for technical merit followed by a programmatic review for relevance to military health and program priorities. Applicants must maintain active registrations in SAM.gov, eBRAP.org, and Grants.gov. Key submission requirements include a three-page Statement of Work, a one-page Innovation Statement, and a one-page Post-Award Transition Plan. All applications must be submitted by the specified deadlines, with full applications from extramural organizations required to go through the Grants.gov Workspace. Special attention is required for the disclosure of foreign affiliations of key personnel and the approval of the DHA R&D Office of Research and Regulatory Compliance for any research involving human or animal subjects.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

5 months ago

DEADLINE

in 10 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS